Back to Search
JAMES BONNER, MD
MD
Radiation Oncology Physician
NPI: 1962442533Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma.
PMID 19616333·Radiother Oncol·2009
4-observational
Is cetuximab active in patients with cisplatin-refractory squamous cell carcinoma of the head and neck?
PMID 17909551·Nat Clin Pract Oncol·2007
8-other
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
PMID 16467544·N Engl J Med·2006
3-trial
Anti-EGFR-mediated radiosensitization as a result of augmented EGFR expression.
PMID 15142629·Int J Radiat Oncol Biol Phys·2004
8-other
Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFr) enhances the radiosensitization properties of anti-EGFr treatment in prostate cancer cells.
PMID 14967455·Int J Radiat Oncol Biol Phys·2004
8-other
Epidermal growth factor receptor as a therapeutic target in head and neck cancer.
PMID 12174340·Semin Radiat Oncol·2002
6-review
The possible use of uniform PORT doses is important in the SEER analysis, but undetected selection bias remains an issue.
PMID 14653875·Clin Lung Cancer·2002
8-other
Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers.
PMID 11060327·J Clin Oncol·2000
8-other
Proliferation and patterning are mediated independently in the dorsal spinal cord downstream of canonical Wnt signaling.
PMID 18062957·Dev Biol·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 619 19TH STREET SOUTH
BIRMINGHAM, AL 35233 - Phone
- (205) 934-6600
Quick Facts
- NPI
- 1962442533
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile